Pharma Unlimited Podcast Series

Five unique episodes on the future of life sciences. Five fascinating lenses on the big issues facing the pharma sector. Join host Bertrand Bodson as he meets some of the biggest names in the technology and life sciences sectors to go under the microscope and ask: what’s the future of pharma? 

health medicine jar medical retail pharmacies icon

Does pharma need a mission reset?


Michelle Nunn – President and CEO of Care USA – discusses how the public and private sectors can work together to ensure advances in pharma and medicine are accessible to all.

Read More About the Episode Here

health needle medicine syringe icon

Safety and efficacy at speed 


Professor Sir John Bell – an instrumental figure in the delivery of the AstraZeneca vaccine – joins host Bertrand Bodson to talk about risk management in a post-pandemic world. 

Read More About the Episode Here

search group people magnifying glass icon

Big Tech – Friend or Foe?


Harvard Business School professor Karim Lakhani discusses the arrival of Big Tech on the pharma scene, and whether the future of medicine is about close competition or closer cooperation.

Read More About the Episode Here

 

health cross digital medical icon

Can Big Tech de-risk personalized medicine?

Peter Lee – Corporate Vice President of Research and Incubation at Microsoft – joins to discuss how pharma companies can resolve the conflict between data-fuelled development and data privacy.

Read More About the Episode Here

 

screen idea light bulb innovative IP rights icon

Can ethics keep pace with pharma innovation?


Klaus Moosmayer – Chief Ethics, Risk & Compliance Officer at Novartis – discusses how ethical standards in the pharma industry can be maintained and met in the face of such change.

Read More About the Episode Here

Managing Risk in Pharma

In a complex and uncertain world, Wolters Kluwer provides a range of solutions that enable the control and mitigation of operational, financial, legal and regulatory risk. 
Lab Pharma Video
Watch Video
The toughest journey in science?

Drug discovery is the riskiest journey in science. It’s also one of the most important. There are more than 70,000 ways for the human body to fail. Each one represents a treatment to be found. But life sciences is unpredictable. Most new treatments fail. Every day brings challenges that can end the life of a drug before it is born. Without risk, the explorer cannot advance. Reach too far and the journey is over.

Every step, Wolters Kluwer is with you.

To push is to risk. Keep pushing.

Latest in Pharma

Our Solutions for Pharma

Our tools enable risk detection, analysis ad prevention from the laboratory to the production line, limiting exposure and enhancing decision making.
Back To Top